Insulin exhibits short-term anti-inflammatory but long-term proinflammatory effects in vitro

Molecular and Cellular Endocrinology

Volumn 298, Issue 1-2, 2009, Pages 25-32

  Iwasaki, Yasumasa ^a   Nishiyama, Mitsuru ^a   Taguchi, Takafumi ^a   Asai, Masato ^b   Yoshida, Masanori ^b   Kambayashi, Machiko ^a   Terada, Yoshio ^a   Hashimoto, Kozo ^a  

^a KOCHI UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherothrombosis; Insulin; Mitogen activated protein kinase; Nuclear factor kappaB; Phosphatidylinositol 3 kinase

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INSULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P50; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANTI-INFLAMMATORY AGENTS; HUMANS; HYPOGLYCEMIC AGENTS; INFLAMMATION; INFLAMMATION MEDIATORS; INSULIN; LIVER; MODELS, BIOLOGICAL; NF-KAPPA B; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 57749195944     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.09.030     Document Type: Article

References (43)

1. Abbasi F., McLaughlin T., Lamendola C., Lipinska I., Tofler G., and Reaven G.M. Comparison of plasminogen activator inhibitor-1 concentration in insulin-resistant versus insulin-sensitive healthy women. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 2818-2821
2. Adler A.I., Neil H.A., Manley S.E., Holman R.R., and Turner R.C. Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47). Am. Heart J. 138 (1999) S353-S359
3. Aoki Y., Iwasaki Y., Katahira M., Oiso Y., and Saito H. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. I. effects of the common secretagogues. Endocrinology 138 (1997) 1923-1929
4. Barnes P.J., and Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336 (1997) 1066-1071
5. Begbie M., Notley C., Tinlin S., Sawyer L., and Lillicrap D. The Factor VIII acute phase response requires the participation of NF-κB and C/EBP. Thromb. Haemost. 84 (2000) 216-222
6. Beraza N., Malato Y., Vander Borght S., Liedtke C., Wasmuth H.E., Dreano M., de Vos R., Roskams T., and Trautwein C. Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis. Gut 57 (2008) 570-572
7. Bing Z., Huang J.H., and Liao W.S. NF-κB interacts with serum amyloid A3 enhancer factor to synergistically activate mouse serum amyloid A3 gene transcription. J. Biol. Chem. 275 (2000) 31616-31623
8. Cha-Molstad H., Agrawal A., Zhang D., Samols D., and Kushner I. The Rel family member p50 mediates cytokine-induced C-reactive protein expression by a novel mechanism. J. Immunol. 165 (2000) 4592-4597
9. Chaudhuri A., Janicke D., Wilson M.F., Tripathy D., Garg R., Bandyopadhyay A., Calieri J., Hoffmeyer D., Syed T., Ghanim H., Aljada A., and Dandona P. Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation 109 (2004) 849-854
10. Dandona P., Aljada A., Mohanty P., Ghanim H., Hamouda W., Assian E., and Ahmad S. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?. J. Clin. Endocrinol. Metab. 86 (2001) 3257-3265
11. Dandona P., Aljada A., and Mohanty P. The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 45 (2002) 924-930
12. Dela Peña A., Leclercq I., Field J., George J., Jones B., and Farrell G. NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis. Gastroenterology 129 (2005) 1663-1674
13. Fontbonne A. Why can high insulin levels indicate a risk for coronary heart disease?. Diabetologia 37 (1994) 953-955
14. Fuller G.M., and Zhang Z. Transcriptional control mechanism of fibrinogen gene expression. Ann. N.Y. Acad. Sci. 936 (2001) 469-479
15. Gruen M.L., Saraswathi V., Nuotio-Antar A.M., Plummer M.R., Coenen K.R., and Hasty A.H. Plasma insulin levels predict atherosclerotic lesion burden in obese hyperlipidemic mice. Atherosclerosis 186 (2005) 54-64
16. Imperatore G., Riccardi G., Iovine C., Rivellese A.A., and Vaccaro O. Plasma fibrinogen: a new factor of the metabolic syndrome. A population-based study. Diabetes Care 21 (1998) 649-654
17. Iwasaki Y., Kambayashi M., Asai M., Yoshida M., Nigawara T., and Hashimoto K. High glucose alone, as well as in combination with proinflammatory cytokines, stimulates nuclear factor kappa-B-mediated transcription in hepatocytes in vitro. J. Diabete. Complications 21 (2007) 56-62
18. Jiang Z.Y., Lin Y.W., Clemont A., Feener E.P., Hein K.D., Igarashi M., Yamauchi T., White M.F., and King G.L. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J. Clin. Invest. 104 (1999) 447-457
19. Kanzaki M., and Pessin J.E. Signal integration and the specificity of insulin action. Cell. Biochem. Biophys. 35 (2001) 191-209
20. Kitamura T., Kahn C.R., and Accili D. Insulin receptor knockout mice. Ann. Rev. Physiol. 65 (2003) 313-332
21. Koskenkari J.K., Kaukoranta P.K., Rimpiläinen J., Vainionpää V., Ohtonen P.P., Surcel H.M., Juvonen T., and Ala-Kokko T.I. Anti-inflammatory effect of high-dose insulin treatment after urgent coronary revascularization surgery. Acta Anaesthesiol. Scand. 50 (2006) 962-969
22. Kubota T., Kubota N., Moroi M., Terauchi Y., Kobayashi T., Kamata K., Suzuki R., Tobe K., Namiki A., Aizawa S., Nagai R., Kadowaki T., and Yamaguchi T. Lack of insulin receptor substrate-2 causes progressive neointima formation in response to vessel injury. Circulation 107 (2003) 3073-3080
23. Larsen L., Størling J., Darville M., Eizirik D.L., Bonny C., Billestrup N., and Mandrup-Poulsen T. Extracellular signal-regulated kinase is essential for interleukin-1-induced and nuclear factor kappaB-mediated gene expression in insulin-producing INS-1E cells. Diabetologia 48 (2005) 2582-2590
24. Leonetti F., Iozzo P., Giaccari A., Sbraccia P., Buongiorno A., Tamburrano G., and Andreani D. Absence of clinically overt atherosclerotic vascular disease and adverse changes in cardiovascular risk factors in 70 patients with insulinoma. J. Endocrinol. Invest. 16 (1993) 875-880
25. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
26. Nathan D.M., Lachin J., Cleary P., Orchard T., Brillon D.J., Backlund J.Y., O'Leary D.H., and Genuth S. Diabetes control and complications trial; epidemiology of diabetes interventions and complications research group. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N. Engl. J. Med. 348 (2003) 2294-2303
27. 3-kinase and Akt/PKB activations in ZDF rat liver. Biochem. Biophys. Res. Commun. 266 (1999) 252-256
28. Reaven G.M. Pathophysiology of insulin resistance in human disease. Physiol. Rev. 75 (1995) 473-486
29. Ruan Q.R., Zhang W.J., Hufnagl P., Kaun C., Binder B.R., and Wojta J. Anisodamine counteracts lipopolysaccharide-induced tissue factor and plasminogen activator inhibitor-1 expression in human endothelial cells: contribution of the NF-κB pathway. J. Vasc. Res. 38 (2001) 13-19
30. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
31. Sato Y., Shiraishi S., Oshida Y., Ishiguro T., and Sakamoto N. Experimental atherosclerosis-like lesions induced by hyperinsulinism in Wistar rats. Diabetes 38 (1989) 91-96
32. Schulze-Osthoff K., Ferrari D., Riehemann K., and Wesselborg S. Regulation of NF-κB activation by MAP kinase cascades. Immunobiology 198 (1997) 35-49
33. Shamir R., Shehadeh N., Rosenblat M., Eshach-Adiv O., Coleman R., Kaplan M., Hamoud S., Lischinsky S., and Hayek T. Oral insulin supplementation attenuates atherosclerosis progression in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 104-110
34. Sista A.K., O'Connell M.K., Hinohara T., Oommen S.S., Fenster B.E., Glassford A.J., Schwartz E.A., Taylor C.A., Reaven G.M., and Tsao P.S. Increased aortic stiffness in the insulin-resistant Zucker fa/fa rat. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H845-H851
35. Standl E. Hyperinsulinemia and atherosclerosis. Clin. Invest. Med. 18 (1995) 261-266
36. Stout R.W. Hyperinsulinemia and atherosclerosis. Diabetes 45 Suppl. 3 (1996) S45-S46
37. Vanden Berghe W., Plaisance S., Boone E., De Bosscher K., Schmitz M.L., Fiers W., and Haegeman G. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem. 273 (1998) 3285-3290
38. Vermeulen L., De Wilde G., Notebaert S., Vanden Berghe W., and Haegeman G. Regulation of the transcriptional activity of the nuclear factor-κB p65 subunit. Biochem. Pharmacol. 64 (2002) 963-970
39. Vermeulen L., De Wilde G., Van Damme P., Vanden Berghe W., and Haegeman G. Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J. 22 (2003) 1313-1324
40. Visser L., Zuurbier C.J., Hoek F.J., Opmeer B.C., de Jonge E., de Mol B.A., and van Wezel H.B. Glucose, insulin and potassium applied as perioperative hyperinsulinaemic normoglycaemic clamp: effects on inflammatory response during coronary artery surgery. Br. J. Anaesth. 95 (2005) 448-457
41. Wang C.C., Goalstone M.L., and Draznin B. Molecular mechanisms of insulin resistance that impact cardiovascular biology. Diabetes 53 (2004) 2735-2740
42. Yamaguchi K., Higashiura K., Ura N., Murakami H., Hyakukoku M., Furuhashi M., and Shimamoto K. The effect of tumor necrosis factor-alpha on tissue specificity and selectivity to insulin signaling. Hypertens. Res. 26 (2003) 389-396
43. Zhang H.X., Zang Y.M., Huo J.H., Liang S.J., Zhang H.F., Wang Y.M., Fan Q., Guo W.Y., Wang H.C., and Gao F. Physiologically tolerable insulin reduces myocardial injury and improves cardiac functional recovery in myocardial ischemic/reperfused dogs. J. Cardiovasc. Pharmacol. 48 (2006) 306-313